# Treatment of Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells

> **NCT04212728** · NA · UNKNOWN · sponsor: **Yantai Yuhuangding Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **BIOLOGICAL:** Auotologous AMSCs plus autologous PRP
- **BIOLOGICAL:** Auotologous PRP

## Key facts

- **NCT ID:** NCT04212728
- **Lead sponsor:** Yantai Yuhuangding Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-29
- **Primary completion:** 2023-12
- **Final completion:** 2024-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04212728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04212728, "Treatment of Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04212728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*